Skip to main content
OpenTrials

Clinical trial condition

Neoplasms

Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.

818 public trials 114 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms trial results

Completed

A Study of IMC-CS4 in Subjects With Advanced Solid Tumors

NCT01346358

Conditions
Neoplasms
Locations
  • The Angeles Clinic & Research Institute Los Angeles, California, United States
  • Univ of California San Francisco San Francisco, California, United States
  • Emory University Atlanta, Georgia, United States
  • Columbia University College of Phys & Surgeons New York, United States
View Trial Details
Completed

A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems

NCT03814005

Conditions
Bone Marrow Diseases, Chronic Disease, Digestive System Diseases, +22 more
Locations
  • Icahn School of Medicine at Mount Sinai New York, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • ICO lHospitalet Hospital Duran i Reynals LHospitalet de Llobregat, Barcelona, Spain
  • Hospital Universitario Vall d'Hebron - PPDS Barcelona, Spain
View Trial Details
Completed

GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors

NCT03693612

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +33 more
Locations
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued.

NCT00378482

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +38 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Tampa, Florida, United States
  • Research Site Ann Arbor, Michigan, United States
  • Research Site New York, United States
View Trial Details
Completed

A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid Tumors

NCT03343054

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan
  • National Cancer Center Hospital East Kashiwa, Chiba, Japan
  • National Hospital Organization Hokkaido Cancer Center Sapporo, Hokkaido, Japan
  • Kanagawa Cancer Center Yokohama, Kanagawa, Japan
View Trial Details

Related conditions